Rathbones Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.47M | Buy |
20,628
+5,463
| +36% | +$1.87M | 0.03% | 180 |
|
|
2026
Q1 | $5.34M | Buy |
15,165
+1,796
| +13% | +$640K | 0.02% | 199 |
|
|
2025
Q4 | $4.38M | Buy |
13,369
+240
| +2% | +$76.1K | 0.02% | 228 |
|
|
2025
Q3 | $3.71M | Buy |
13,129
+193
| +1% | +$56K | 0.02% | 242 |
|
|
2025
Q2 | $3.61M | Sell |
12,936
-23
| -0.2% | -$6.52K | 0.02% | 239 |
|
|
2025
Q1 | $4.04M | Buy |
12,959
+1,285
| +11% | +$379K | 0.02% | 216 |
|
|
2024
Q4 | $3.04M | Sell |
11,674
-192
| -2% | -$57K | 0.01% | 244 |
|
|
2024
Q3 | $3.82M | Buy |
11,866
+92
| +0.8% | +$30.1K | 0.02% | 214 |
|
|
2024
Q2 | $3.68M | Buy |
11,774
+2,054
| +21% | +$603K | 0.02% | 215 |
|
|
2024
Q1 | $2.76M | Buy |
9,720
+608
| +7% | +$178K | 0.02% | 233 |
|
|
2023
Q4 | $2.62M | Buy |
9,112
+184
| +2% | +$50.1K | 0.02% | 236 |
|
|
2023
Q3 | $2.4M | Buy |
8,928
+802
| +10% | +$200K | 0.02% | 243 |
|
|
2023
Q2 | $1.8M | Sell |
8,126
-35,000
| -81% | -$8.12M | 0.02% | 212 |
|
|
2023
Q1 | $10.4M | Sell |
43,126
-4,300
| -9% | -$1.06M | 0.11% | 119 |
|
|
2022
Q4 | $12.5M | Sell |
47,426
-46,151
| -49% | -$12.4M | 0.14% | 118 |
|
|
2022
Q3 | $21.1M | Sell |
93,577
-29,122
| -24% | -$7.06M | 0.26% | 90 |
|
|
2022
Q2 | $29.9M | Sell |
122,699
-1,100
| -0.9% | -$270K | 0.34% | 76 |
|
|
2022
Q1 | $29.9M | Buy |
123,799
+4,665
| +4% | +$1.07M | 0.31% | 84 |
|
|
2021
Q4 | $26.8M | Buy |
119,134
+3,800
| +3% | +$802K | 0.26% | 90 |
|
|
2021
Q3 | $24.5M | Buy |
115,334
+1,296
| +1% | +$298K | 0.26% | 89 |
|
|
2021
Q2 | $27.8M | Buy |
114,038
+14,055
| +14% | +$3.46M | 0.31% | 81 |
|
|
2021
Q1 | $24.9M | Buy |
99,983
+4,307
| +5% | +$1.03M | 0.32% | 79 |
|
|
2020
Q4 | $22M | Buy |
95,676
+9,121
| +11% | +$2.1M | 0.31% | 75 |
|
|
2020
Q3 | $22M | Buy |
86,555
+2,345
| +3% | +$581K | 0.38% | 67 |
|
|
2020
Q2 | $19.9M | Buy |
84,210
+6,572
| +8% | +$1.5M | 0.4% | 61 |
|
|
2020
Q1 | $15.7M | Buy |
77,638
+9,980
| +15% | +$2.18M | 0.46% | 58 |
|
|
2019
Q4 | $16.3M | Sell |
67,658
-22,680
| -25% | -$5M | 0.43% | 63 |
|
|
2019
Q3 | $17.5M | Buy |
90,338
+29,193
| +48% | +$5.6M | 0.5% | 63 |
|
|
2019
Q2 | $11.3M | Sell |
61,145
-32
| -0.1% | -$5.73K | 0.35% | 67 |
|
|
2019
Q1 | $11.6M | Sell |
61,177
-5,952
| -9% | -$1.14M | 0.38% | 66 |
|
|
2018
Q4 | $13.1M | Buy |
67,129
+468
| +0.7% | +$91.3K | 0.5% | 57 |
|
|
2018
Q3 | $13.8M | Sell |
66,661
-362
| -0.5% | -$71.3K | 0.47% | 57 |
|
|
2018
Q2 | $12.4M | Buy |
67,023
+5,329
| +9% | +$943K | 0.47% | 53 |
|
|
2018
Q1 | $10.5M | Buy |
61,694
+5,695
| +10% | +$1.05M | 0.43% | 61 |
|
|
2017
Q4 | $9.74M | Buy |
55,999
+2,128
| +4% | +$377K | 0.4% | 66 |
|
|
2017
Q3 | $10M | Buy |
53,871
+3,730
| +7% | +$661K | 0.44% | 63 |
|
|
2017
Q2 | $8.64M | Buy |
50,141
+8,800
| +21% | +$1.43M | 0.38% | 70 |
|
|
2017
Q1 | $6.78M | Buy |
41,341
+1,169
| +3% | +$194K | 0.31% | 78 |
|
|
2016
Q4 | $5.87M | Sell |
40,172
-110,973
| -73% | -$16.7M | 0.29% | 78 |
|
|
2016
Q3 | $25.2M | Buy |
151,145
+5,450
| +4% | +$922K | 1.3% | 23 |
|
|
2016
Q2 | $22.2M | Buy |
145,695
+9,025
| +7% | +$1.4M | 1.22% | 25 |
|
|
2016
Q1 | $20.5M | Sell |
136,670
-63
| -0% | -$9.36K | 1.25% | 25 |
|
|
2015
Q4 | $20.9M | Buy |
136,733
+12,776
| +10% | +$2.01M | 1.33% | 21 |
|
|
2015
Q3 | $17.1M | Buy |
123,957
+6,195
| +5% | +$977K | 1.14% | 27 |
|
|
2015
Q2 | $18.1M | Sell |
117,762
-117
| -0.1% | -$18.7K | 1.17% | 24 |
|
|
2015
Q1 | $18.8M | Buy |
117,879
+2,195
| +2% | +$346K | 1.25% | 24 |
|
|
2014
Q4 | $18.4M | Hold |
115,684
| – | – | 1.21% | 22 |
|
|
2014
Q3 | $16.2M | Buy |
115,684
+113,885
| +6,330% | +$14.9M | 1.13% | 21 |
|
|
2014
Q2 | $213K | Hold |
1,799
| – | – | 0.02% | 262 |
|
|
2014
Q1 | $222K | Buy |
+1,799
| New | +$218K | 0.02% | 249 |
|
Other funds holding AMGN
FFM
SP
Rathbones Group's AMGN Position: Q2 2026 in Review
Rathbones Group increased its Amgen (AMGN) stake by 36% in Q2 2026, buying an estimated $1.87M and bringing the position to 20,628 shares worth $7.47M. The position accounts for 0.03% of the portfolio, ranked #180.
Rathbones Group first reported a position in AMGN in Q1 2014 and has held it in 50 quarters since. The position peaked at $29.9M in Q1 2022. 1,276 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Rathbones Group held 20,628 shares of Amgen worth $7.47M as of Q2 2026.
- Rathbones Group bought 5,463 Amgen shares in Q2 2026, an estimated $1.87M.
- Amgen made up 0.03% of Rathbones Group's portfolio in Q2 2026, its #180 holding.
- Rathbones Group first reported a position in Amgen in Q1 2014 and has held it in 50 quarters since.
- Rathbones Group's Amgen position peaked at $29.9M in Q1 2022.
- 1,276 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.